Rivista
/
/
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
JoVE Journal
Biologia
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Biologia
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
DOI:

18:08 min

December 31, 2007

Capitoli

  • 00:00Introduction
  • 00:44Physiological Role of CD1
  • 04:52CD1d Tetramers
  • 06:57Use of CD1d Tetramers in the Lab
  • 08:46CD1d Tetramer Generation
  • 11:40Therapeutic Utility of NKT Cells
  • 14:43Mucosal Immunity
  • 16:13Future of Immunology

Summary

Traduzione automatica

Natural Killer T cells (NKT) are critical determinants of the immune response to cancer, regulation of autioimmunity, clearance of infection, and the development of artheriosclerotic plaques. In this interview, Mitch Kronenberg discusses his laboratory's efforts to understand the mechanism through which NKT cells are activated by glycolipid antigens.

Video correlati

Read Article